Patient Generated Health Data Market is driven by consumer demand for proactive healthcare management
The global patient generated health data market allows individuals to play an active role in their own healthcare management and decision-making. Patient generated health data refers to health-related data created, recorded, gathered or inferred by or from patients or their designees to help address a health concern. This includes data gathered from tools and medical records to help track symptoms, treatment adherence, outcomes, or other indicators of health that are outside of clinical health records. The ability to easily collect and share personal health data can help identify potential problems early, monitor existing conditions, and get medical advice remotely without visiting a doctor's office. It also allows patients to take a more proactive role in their own health, fitness and wellness.
The global patient generated health data market size was valued at US$ 5.80 Bn in 2023 and is expected to reach US$ 19.06 Bn by 2030, growing at a Compound Annual Growth Rate (CAGR) of 18.5% from 2023 to 2030.
Key Takeaways
Key players operating in the global patient generated health data market includes Ancestry, Gene By Gene, Ltd., 23andMe,Inc., Color Genomics,Inc, Myriad Genetics,Inc, Mapmygenome, Positive Biosciences, Ltd, Futura Genetics, Helix OpCo LLC, MyHeritage Ltd., Pathway Genomics, Veritas, Amgen, Inc., Xcode Life, Diagnomics, Inc., Toolbox Genomics, SomaLogic, Inc., inui Health, AgeCurve, QuickCheck Health, Biomeb, Metabolomic Discoveries GmbH, and Illumina, Inc.
The growing Global Patient Generated Health Data Market Size wearables is driving the market as they allow patients to easily track and share health data. Devices like FitBits, Apple Watches and glucose monitors make it simple to monitor vitals, activity levels and other metrics without visiting a doctor.
Get More Insights on- Patient Generated Health Data Market
The global patient generated health data market allows individuals to play an active role in their own healthcare management and decision-making. Patient generated health data refers to health-related data created, recorded, gathered or inferred by or from patients or their designees to help address a health concern. This includes data gathered from tools and medical records to help track symptoms, treatment adherence, outcomes, or other indicators of health that are outside of clinical health records. The ability to easily collect and share personal health data can help identify potential problems early, monitor existing conditions, and get medical advice remotely without visiting a doctor's office. It also allows patients to take a more proactive role in their own health, fitness and wellness.
The global patient generated health data market size was valued at US$ 5.80 Bn in 2023 and is expected to reach US$ 19.06 Bn by 2030, growing at a Compound Annual Growth Rate (CAGR) of 18.5% from 2023 to 2030.
Key Takeaways
Key players operating in the global patient generated health data market includes Ancestry, Gene By Gene, Ltd., 23andMe,Inc., Color Genomics,Inc, Myriad Genetics,Inc, Mapmygenome, Positive Biosciences, Ltd, Futura Genetics, Helix OpCo LLC, MyHeritage Ltd., Pathway Genomics, Veritas, Amgen, Inc., Xcode Life, Diagnomics, Inc., Toolbox Genomics, SomaLogic, Inc., inui Health, AgeCurve, QuickCheck Health, Biomeb, Metabolomic Discoveries GmbH, and Illumina, Inc.
The growing Global Patient Generated Health Data Market Size wearables is driving the market as they allow patients to easily track and share health data. Devices like FitBits, Apple Watches and glucose monitors make it simple to monitor vitals, activity levels and other metrics without visiting a doctor.
Get More Insights on- Patient Generated Health Data Market
3 days ago
